Anti-Kv4.2/KCND2 antibody [EP982Y]
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Monoclonal Kv4.2/KCND2 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
KIAA1044, KCND2, A-type voltage-gated potassium channel KCND2, Potassium voltage-gated channel subfamily D member 2, Voltage-gated potassium channel subunit Kv4.2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kv4.2/KCND2 antibody [EP982Y] (AB46797)
This data was developed using ab46797, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded human cerebrum tissue sections labeling Kv4.2/KCND2 with purified ab46797 at 1/100 dilution. ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Sections were counterstained with Hematoxylin.
Antigen retrieval was heat mediated antigen retrieval using citrate buffer, pH 6.0).
- WB
Unknown
Western blot - Anti-Kv4.2/KCND2 antibody [EP982Y] (AB46797)
All lanes:
Western blot - Anti-Kv4.2/KCND2 antibody [EP982Y] (ab46797) at 1/1000 dilution
All lanes:
Human brain lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 71 kDa
Observed band size: 25 kDa,80 kDa
false
- WB
CiteAb
Western blot - Anti-Kv4.2/KCND2 antibody [EP982Y] (AB46797)
Kv4.2/KCND2 western blot using anti-Kv4.2/KCND2 antibody [EP982Y] ab46797. Publication image and figure legend from Cacace, R., Heeman, B., et al., 2019, Acta Neuropathol, PubMed 30874922.
ab46797 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab46797 please see the product overview.
RNA and protein expression levels of DPP6 missense variants. a Scatter plot of the DPP6 mRNA expression levels in patients (n = 3) compared to control individuals (n = 4). Each circle (patients) or square (control individuals) represents a single measurement; the graph reports the mean ± standard error of the mean (s.e.m.). **p value = 0.0096. b DPP6 mRNA expression level results of three experiments for each of the variants (grey bars) compared to averaged data of four controls (black bar). c Western blot of DPP6 carriers and control individuals and e western blot of Kv4.2 in DPP6 variant carriers and control individuals. d, f Quantification of the expression levels of DPP6 (d) and Kv4.2 (f), obtained from pooling two independent protein preparations within the same western blot experiment. Quantifications are shown for each of the missense variants (grey bars) compared to control individuals (n = 3, black bar). The relative protein expression is reported as average ± standard deviation of three independent protein preparations and quantifications per sample *p < 0.05, **p < 0.005
false
Related conjugates and formulations (1)
-
Anti-Kv4.2/KCND2 antibody [EP982Y] - BSA and Azide free
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Kv4.2 protein contributes to the transient outward potassium current known as I_A. It often associates with other accessory proteins like KChIP and DPP10 to form functional Kv4.2 channel complexes. These complexes are critical in shaping the signal transmission in neurons affecting synaptic plasticity and neuronal excitability. Kv4.2's action impacts the duration and frequency of neuronal firing influencing functions such as memory and learning.
Pathways
Kv4.2 is integral to the regulation of neuronal excitability in the context of signal transduction pathways. One well-studied pathway involves its role in the MAPK/ERK signaling cascade where Kv4.2 undergoes phosphorylation events that fine-tune its activity. This pathway includes proteins like ERK which interacts with Kv4.2 to affect how neurons respond to synaptic inputs. Kv4.2 is also interconnected with CaMKII signaling which modulates its trafficking and expression in neurons.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Stem cells translational medicine 11:753-766 PubMed35639962
2022
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica 137:901-918 PubMed30874922
2019
Applications
WB
Species
Human
Neurobiology of disease 36:81-95 PubMed19596445
2009
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com